Latest Product Pipeline News

Zimi Limited has secured $2.495 million through a capital raising, appointed new board members, and initiated cost-saving measures exceeding $400,000 annually, while navigating a compliance issue affecting sales to a major distributor.

Austral Resources Australia Ltd reports steady operational progress and promising resource developments in its December 2024 quarter, while navigating an ongoing recapitalisation and leadership transition.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.

Horizon Minerals reports a $14 million placement and a proposed merger with Poseidon Nickel, alongside key production milestones including the first gold pour at Boorara and a prefeasibility study at Penny's Find.

Dropsuite Limited posted a standout quarter with a 37% rise in annual recurring revenue and a 42% jump in paid users, underscoring the strength of its partner ecosystem and product innovation.

Aurora Labs has secured significant contracts in the Defence sector, advancing its micro gas turbine technology and expanding production capabilities following a successful capital raise.

Complii FinTech Solutions Ltd reports a robust Q2 FY25 with a $3.048 million cash balance, a net operational cash inflow, and a 12.9% year-on-year increase in Annual Recurring Revenue, driven by strategic divestment and focused growth initiatives.

Terramin Australia’s attempt to secure a mining lease for its Bird in Hand Gold Project has been rejected by the South Australian Supreme Court, which upheld the government’s refusal and reservation of the land. The company is set to appeal, keeping the project’s future uncertain.

Genesis Minerals Limited reported a record December quarter gold production of 57,055oz, driven by an accelerated Laverton mill restart and strong operational execution. The company’s cash reserves surged 34% to A$238 million, underpinning its debt-free growth strategy.

Horizon Minerals has poured its first gold bar from the Boorara Gold Project, initiating production under a key ore sale agreement and setting the stage for a sustainable gold pipeline.

Telix Pharmaceuticals has exceeded its full-year 2024 revenue guidance, driven by strong sales of its prostate cancer diagnostic Illuccix® and strategic pipeline advancements.